"Ixekizumab induced pleuritis" by Rami Batarseh, Kyle Smith et al.

Article Title

When Treating Sick Joints Harms Lungs, Ixekizumab induced Pleural Effusion

Authors

Rami Batarseh, Joan C Edwards School of Medicine / Marshall UniversityFollow
Kyle Smith, Joan C Edwards School of medicine, Marshall UniversityFollow
Mohammed Al-Ourani, Marshall UniversityFollow
Amro K. Al-Astal, Marshall University Joan C. Edwards School of MedicineFollow

Author Credentials

Rami Batarseh MD Kyle Smith MD Mohammed Al-Ourani MD Amro K. Al-Astal MD

Keywords

Ixekizumab, Pleural effusion, pleuritis, Immune Therapy

Disciplines

Biological Factors | Internal Medicine | Medicine and Health Sciences | Pulmonology | Rheumatology

Abstract

Immunological therapies have provided a multitude of new and effective treatment strategies for various disease states. While monoclonal antibody therapy benefits many patients, side effects are widely variable. here we present a case of pleural effusion complicating psoriatic arthritis treatment.

Recommended Citation

Batarseh, Rami; Smith, Kyle; Al-Ourani, Mohammed; and Al-Astal, Amro K. (2020) "When Treating Sick Joints Harms Lungs, Ixekizumab induced Pleural Effusion," Marshall Journal of Medicine: Vol. 6: Iss. 2, Article 11.
DOI: 10.33470/2379-9536.1262
Available at: https://mds.marshall.edu/mjm/vol6/iss2/11

Download